Delivery Order SPE2DB20D7059-SPE2DB24FPYH9
Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $6.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GLATIRAMER 40 MG/ML SYRINGE medications. The contract has a completion date of February 16, 2024 and a potential value of $2,832.12. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering the pharmaceutical products to DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Glatiramer 40 mg/mL syringe. The award has a ceiling value of $2,832.12 and an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564082002 - GLATIRAMER 40 MG/ML SYRINGEML. The award, valued at $2,937.92, has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Glatiramer 40 mg/ml syringes, a pharmaceutical product, with a potential value of $2,832.12. The contract is a firm fixed price delivery order with a completion date of January 5, 2024. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- The Defense Logistics Agency Troop Support Medical awarded a $15,409.35 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40 mg/ml syringes of glatiramer, to be delivered from its Conshohocken, Pennsylvania facility by August 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. This order is likely associated with the DLA's stocking and distribution of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of glatiramer 40 mg/mL syringes, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,888.11 and a period of performance through April 23, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The award is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, with a potential value of $2,832.12 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order valued at $2,930.01 to AmerisourceBergen Drug Corp for Glatiramer 40 mg/ml syringes, with an ultimate completion date of June 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...